NASDAQ:VTVT | Free Cash Flow | vTv Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$9.15M
2025-12-31-$9.25M
2025-03-31-$5.69M
2024-12-31-$4.83M
2024-03-31-$7.34M
2023-12-31-$2.91M$0.00-$2.91M
2023-03-31-$5.17M
2022-12-31-$6.88M$0.00-$6.88M
2022-03-31-$1.02M
2021-12-31-$6.42M$0.00-$6.42M
2021-03-31-$5.3M
2020-12-31-$2.21M
2020-03-31-$5.56M
2019-12-31-$5.88M
2019-03-31-$5.45M
2018-12-31-$5.87M$0.00-$5.87M
2018-03-31-$5.4M
2017-12-31-$6.33M$18,000.00-$6.35M
2017-03-31-$13.82M$39,000.00-$13.86M
2016-12-31-$11.43M$0.00-$11.43M
2016-03-31-$12.5M
2015-12-31-$8.97M$62,000.00-$9.03M
2015-03-31-$9.37M$4,000.00-$9.37M
2014-12-31-$6.98M-$2,000.00-$6.98M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$25.26M
2024-12-31-$25.31M$0.00-$25.31M
2023-12-31-$19.08M$0.00-$19.08M
2022-12-31-$16.02M$21,000.00-$16.04M
2021-12-31-$19.31M$0.00-$19.31M
2020-12-31-$18M$0.00-$18M
2019-12-31-$23.02M$70,000.00-$23.09M
2018-12-31-$26.86M$5,000.00-$26.86M
2017-12-31-$44.56M$57,000.00-$44.62M
2016-12-31-$48.21M$87,000.00-$48.3M
2015-12-31-$36.95M$104,000.00-$37.05M
2014-12-31-$30.78M$33,000.00-$30.81M
2013-12-31-$41.68M$181,000.00-$41.87M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.